Waystar shares tumble 7% on weak fiscal 2026 guidance
Waystar Holding Corp (WAY) reported Q3 earnings of $0.44 per share, beating estimates, with revenue up 21% YoY to $325.6M. However, shares fell 7.3% on weak fiscal 2026 guidance, with projected EPS of $1.63-$1.71 and revenue of $1.277B-$1.287B, both below consensus. The company reported 10% net income margin and 43% adjusted EBITDA margin.
How this was made
The 30-second read
Why it matters
The guidance miss is the primary catalyst for the stock's move, suggesting near‑term downside risk.
Market read
The earnings release and guidance revision are material for traders, prompting immediate price action.
What to watch
Strong net revenue retention (108%) and growing subscription revenue could support future upside despite short‑term guidance shortfall.
Background
Waystar reported Q3 earnings that beat estimates but issued FY2026 guidance below consensus, causing a notable after‑hours price decline.
Ticker impact
Shares fell 7.3% in after‑hours trading as Waystar's FY2026 guidance missed Wall Street expectations.
downward pressure as the market prices in the weaker FY2026 guidance.
The company projected FY2026 EPS $1.63‑$1.71 and revenue $1.277‑$1.287 B, both below analyst expectations, triggering a 7% post‑earnings sell‑off.
Market effects
May weigh on other healthcare‑payment software firms as investors reassess revenue growth assumptions.
Limited to U.S. markets; no broader regional effect.
Low global relevance beyond the niche sector.
Counterpoint
If Waystar can sustain AI‑driven platform adoption, the guidance miss may be temporary and present a buying opportunity on the dip.
Key entities
- companyWaystar Holding Corp
Healthcare payment software provider reporting Q3 results and FY2026 guidance.
